If you are interested in understanding how to optimise analytical methods to accelerate biosimilar development, watch this exclusive DDW event, supported by Bio-Techne. Using an automated CE-SDS platform in efficient biosimilar comparability studies, which took place on 29 September at 4PM BST.
Watch on Demand here.
In this webinar, Dr. Richard L. Easton, Technical Director of Structural Analysis at BioPharmaSpec, discusses the use of the automated Maurice platform to provide capillary electrophoresis-sodium dodecyl sulphate (CE-SDS) data for biosimilar comparability studies.
BioPharmaSpec is a CRO, specialising in the structural and physicochemical characterisation of biopharmaceuticals, with technical expertise in Antibody Drug Conjugates, biosimilars and many more.
Maurice allows for both CE-SDS and icIEF (imaged capillary isoelectric focusing) analyses. These instruments are designed to significantly reduce run times (as short as 25-35 minutes) while providing high-quality and reproducible results. Through UV absorbance (220 nm), high-resolution peaks are obtained for proteins ranging from 10 kDa to 270 kDa.
Easton will present data from studies with monoclonal antibodies, heavily glycosylated species and PEGylated species showing how the Maurice platform can be used to provide reliable insights into the structure of different types of biopharmaceuticals, including assessments of size heterogeneity, presence of partial species in monoclonal antibody preparations, impurity analyses and batch to batch comparability. This webinar will benefit anyone who is interested in understanding how to optimise their analytical methods to accelerate biosimilar development.
Learning Objectives:
- Learn how the automated Maurice platform to provide capillary electrophoresis-sodium dodecyl sulphate (CE-SDS) data for biosimilar comparability studies.
- Learn how the Maurice platform can be used to provide reliable insights into the structure of different types of biopharmaceuticals.
- Find out how you canoptimiseyour analytical methods to accelerate biosimilar development.
Watch for free here.
